default search action

combined dblp search
author search
venue search
publication search

ask others

Ursula Creutzig

> Home > Persons

Person information

Refine list

refinements active!

zoomed in on ?? of ?? records

view refined list in

export refined list as

showing all ?? records

2000 – 2009

see FAQ

What is the meaning of the colors in the publication lists?

2002
[j1]
- view
  authority control:
- export record
  dblp key:
  - journals/artmed/KnaupWBCHS02
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/artmed/KnaupWBCHS02
Petra Knaup, Timm Wiedemann, Andreas Bachert, Ursula Creutzig, Reinhold Haux, Freimut Schilling:
Efficiency and safety of chemotherapy plans for children: CATIPOa nationwide approach. Artif. Intell. Medicine 24(3): 229-242 (2002)

1990 – 1999

see FAQ

What is the meaning of the colors in the publication lists?

1999
[c2]
- view
  authority control:
- export record
  dblp key:
  - conf/xps/KnaupWBCHSS99
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/xps/KnaupWBCHSS99
Petra Knaup, Timm Wiedemann, Andreas Bachert, Ursula Creutzig, Reinhold Haux, Michael Schäfer, Freimut Schilling:
Experiences of Using a Computer-Aided Therapy Planning for Pediatric Oncology in Clinical Routine. XPS 1999: 210-217
1998
[c1]
- view
  - electronic edition via DOI (open access)
  - references & citations
  authority control:
- export record
  dblp key:
  - conf/medinfo/WiedemannKBCHS98
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/medinfo/WiedemannKBCHS98
Timm Wiedemann, Petra Knaup, Andreas Bachert, Ursula Creutzig, Reinhold Haux, Freimut Schilling:
Computer-aided Documentation and Therapy Planning in Pediatric Oncology. MedInfo 1998: 1306-1309

Coauthor Index

see FAQ

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.